TrialTransplantation2020

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study).

Tommaso Maria Manzia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.